pharma news today obesity drugs glp-1 𧬠Could this be the future of treatment? Scientists in Germany have developed an experimental βTrojan Horseβ weight-loss drug designed to outperform existing therapies like Ozempic and Wegovy. The next-generation treatment How are GLP-1 drugs impacting
Description
For research professionals, the practical implications are clear
P = 0.21
Fujita H, Taniai H, Murayama H, et al
Is Trulicity the same as Rybelsus
Many are trying to address this by expanding their range of protein-rich products and creating GLP-1 companion products, but it probably wont be enough
An inverse correlation is observed between plasma PYY and BMD in populations with weight gain and obesity (decreased PYY and increased BMD) and in weight loss scenarios (increased PYY and decreased BMD), as observed in patients with anorexia and amenorrheic athletes [81]
